Bioburden

Bioburden is not just a test result — it is the input that sizes everything downstream. A bioburden-based sterilisation cycle is validated against the number and resistance of the organisms actually present, so if bioburden rises or goes uncharacterised, the cycle may no longer deliver the sterility assurance level it was designed for. Control the bioburden and the sterilisation stays valid; let it drift and the safety margin erodes silently.

For non-sterile products, bioburden is itself a quality attribute — the assurance that a tablet, cream, or liquid does not carry an objectionable microbial load to the patient. In both cases it doubles as a process-health signal: a step change in counts is often the first evidence of a failing water system, a fouled line, or a breakdown in cleaning.

Numbers alone are not enough. A count can sit inside its numerical limit yet still be unacceptable if the organism recovered is pathogenic or capable of degrading the product for its route of administration. Good microbial control therefore identifies what grew, not only how much, and treats repeat recovery of the same organism as a route to be found and closed.

• —Pre-sterilisation bioburden determines whether a validated sterilisation cycle still achieves its sterility assurance level.
• —Recovery must be demonstrated for the specific product matrix — an unvalidated method makes a low count meaningless.
• —Alert levels are early warnings; action levels require documented investigation. The value is in the trend, not one result.
• —Objectionable organisms can fail a sample that is numerically within limit — identify what grows, not just the count.
• —Cheaper and more reliable to keep bioburden low upstream (facility, water, cleaning, gowning) than to rely on sterilisation to rescue a dirty process.

USP <61> (Microbial Enumeration Tests) and USP <62> (Tests for Specified Microorganisms) for non-sterile products; USP <71> (Sterility Tests); USP <1115> (Bioburden Control of Non-sterile Drug Substances and Products); ISO 11737-1 for medical devices; EU GMP Annex 1 (2022) for contamination control in sterile manufacture.